{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:08:00Z","timestamp":1715983680785},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T00:00:00Z","timestamp":1296086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00774-010-0247-3","type":"journal-article","created":{"date-parts":[[2011,1,26]],"date-time":"2011-01-26T03:33:24Z","timestamp":1296012804000},"page":"484-492","source":"Crossref","is-referenced-by-count":7,"title":["Association between ER-\u03b1 polymorphisms and bone mineral density in patients with Turner syndrome subjected to estroprogestagen treatment\u2014a pilot study"],"prefix":"10.1007","volume":"29","author":[{"given":"El\u017cbieta","family":"Sowi\u0144ska-Przepiera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Andrysiak-Mamos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kornel","family":"Che\u0142stowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gra\u017cyna","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbigniew","family":"Friebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anhelli","family":"Syrenicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,27]]},"reference":[{"key":"247_CR1","first-page":"40","volume":"7","author":"A Wi\u015bniewski","year":"1993","unstructured":"Wi\u015bniewski A (1993) Women with Turner\u2019s syndrome are among your patients. Klinika 7:40\u201343","journal-title":"Klinika"},{"key":"247_CR2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/bmj.312.7022.16","volume":"312","author":"CH Gravholt","year":"1996","unstructured":"Gravholt CH, Juul S, Naeraa RW, Hansen J (1996) Prenatal and postnatal prevalence of Turner\u2019s syndrome: a registry study. Br Med J 312:16\u201321","journal-title":"Br Med J"},{"key":"247_CR3","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1365-2265.1999.00720.x","volume":"50","author":"CH Gravholt","year":"1999","unstructured":"Gravholt CH, Svenstrup B, Bennet P, Sandahl Christiansen J (1999) Reduced androgen levels in adult Turner syndrome: influence of female sex steroids and growth hormone status. Clin Endocrinol 50:791\u2013800","journal-title":"Clin Endocrinol"},{"key":"247_CR4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2265.1999.00841.x","volume":"51","author":"K Landin-Wilhemsen","year":"1999","unstructured":"Landin-Wilhemsen K, Bryman I, Windh M, Wilhelmsen L (1999) Osteoporosis and fractures in Turner syndrome: importance of growth promoting and oestrogen therapy. Clin Endocrinol 51:497\u2013502","journal-title":"Clin Endocrinol"},{"key":"247_CR5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/eje.0.1380059","volume":"138","author":"L Even","year":"1998","unstructured":"Even L, Bronstein V, Hochberg Z (1998) Bone maturation in girls with Turner\u2019s syndrome. Eur J Endocrinol 138:59\u201362","journal-title":"Eur J Endocrinol"},{"key":"247_CR6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11154-008-9076-2","volume":"9","author":"VK Bakalov","year":"2008","unstructured":"Bakalov VK, Bondy CA (2008) Fracture risk and bone mineral density in Turner syndrome. Rev Endocr Metab Disord 9:145\u2013151","journal-title":"Rev Endocr Metab Disord"},{"key":"247_CR7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s007740200042","volume":"20","author":"AM Costa","year":"2002","unstructured":"Costa AM, Lemos-Marini SH, Baptista MT, Morcillo AM, Maciel-Guerra AT, Guerra G (2002) Bone mineralization in Turner syndrome: a transverse study of the determinant factors in 58 patients. J Bone Miner Metab 20:294\u2013297","journal-title":"J Bone Miner Metab"},{"key":"247_CR8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1542\/peds.102.S3.481","volume":"102","author":"K Rubin","year":"1998","unstructured":"Rubin K (1998) Turner syndrome and osteoporosis: mechanism and prognosis. Pediatrics 102:481\u2013485","journal-title":"Pediatrics"},{"key":"247_CR9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2265.1995.tb00544.x","volume":"43","author":"MC Davies","year":"1995","unstructured":"Davies MC, Gulekli B, Jacobs HS (1995) Osteoporosis in Turner\u2019s syndrome and other forms of primary amenorrhea. Clin Endocrinol 43:741\u2013746","journal-title":"Clin Endocrinol"},{"key":"247_CR10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02565125","volume":"49","author":"RW Naeraa","year":"1991","unstructured":"Naeraa RW, Brixen K, Hansen RM, Hasling C, Mosekilde L, Andresen JH, Charles P, Nielsen J (1991) Skeletal size and bone mineral content in Turner\u2019s syndrome: relation to karyotype, estrogen treatment, physical fitness and bone turnover. Calc Tiss Int 49:77\u201383","journal-title":"Calc Tiss Int"},{"key":"247_CR11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.cmet.2007.09.007","volume":"6","author":"DV Novack","year":"2007","unstructured":"Novack DV (2007) Estrogen and bone: osteoclasts take center stage. Cell Metab 6:254\u2013256","journal-title":"Cell Metab"},{"key":"247_CR12","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.4161\/cc.7.10.5892","volume":"7","author":"SA Krum","year":"2008","unstructured":"Krum SA, Brown M (2008) Unraveling estrogen action in osteoporosis. Cell Cycle 7:1348\u20131352","journal-title":"Cell Cycle"},{"key":"247_CR13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1507\/endocrj.50.263","volume":"50","author":"N Suganuma","year":"2003","unstructured":"Suganuma N, Furuhashi M, Hirooka T, Moriwaki T, Hasegawa Y, Mori O, Ogawa M (2003) Bone mineral density in adult patients with Turner\u2019s syndrome: analyses of the effectiveness of GH and ovarian steroids hormone replacement therapies. Endocr J 50:263\u2013269","journal-title":"Endocr J"},{"key":"247_CR14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1359\/jbmr.1998.13.4.695","volume":"13","author":"M Willing","year":"1998","unstructured":"Willing M, Sowers M, Aron D, Clark MK, Burns T, Bunten C, Crutchfield M, D\u2019Agostino D, Jannausch M (1998) Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 13:695\u2013705","journal-title":"J Bone Miner Res"},{"key":"247_CR15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1210\/jc.83.3.939","volume":"83","author":"L Gennari","year":"1998","unstructured":"Gennari L, Becherini L, Masi L, Mansani R, Gonnelli S, Cepollaro C, Martini S, Montagnani A, Lentini G, Becorpi AM, Brandi ML (1998) Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density. J Clin Endocrinol Metab 83:939\u2013944","journal-title":"J Clin Endocrinol Metab"},{"key":"247_CR16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1210\/jc.2003-030691","volume":"89","author":"M Sowers","year":"2004","unstructured":"Sowers M, Jannausch ML, Liang W, Willing M (2004) Estrogen receptor genotypes and their association with the 10-year changes in bone mineral density and osteocalcin concentrations. J Clin Endocrinol Metab 89:733\u2013739","journal-title":"J Clin Endocrinol Metab"},{"key":"247_CR17","first-page":"72","volume":"153","author":"RW Nearaa","year":"1993","unstructured":"Nearaa RW, Nielsen J, Kastrup KW (1993) Growth hormone and 17-\u03b2 estradiol treatment of Turner girls\u20142-year results. Eur J Pediatr 153:72\u201377","journal-title":"Eur J Pediatr"},{"key":"247_CR18","first-page":"197","volume-title":"Basic and clinical approach to Turner syndrome","author":"Y Igarashi","year":"1993","unstructured":"Igarashi Y, Ogawa E, Fujieda K, Tanaka T (1993) Treatment of Turner syndrome with transdermal 17-\u03b2-estradiol. In: Hibi I, Takano K (eds) Basic and clinical approach to Turner syndrome. Elsevier, Amsterdam, pp 197\u2013202"},{"key":"247_CR19","first-page":"145","volume":"56","author":"E Sowi\u0144ska-Przepiera","year":"2005","unstructured":"Sowi\u0144ska-Przepiera E, Andrysiak-Mamos E, Friebe Z, Kapczuk K, Pilarska K (2005) The effect of primary lack of estrogens and the influence of the age at the beginning of estrogen therapy on bone mineral density in patients with Turner\u2019s syndrome. Pol J Endocrinol 56:145\u2013153","journal-title":"Pol J Endocrinol"},{"key":"247_CR20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/adc.50.1.14","volume":"50","author":"JM Tanner","year":"1975","unstructured":"Tanner JM, Whitehouse RH, Marshal WA, Carter BS (1975) Prediction of adult height from height, bone age, and occurrence of menarche, at ages 4 to 16 with allowance for midparent height. Arch Dis Child 50:14\u201326","journal-title":"Arch Dis Child"},{"key":"247_CR21","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJM198311033091806","volume":"309","author":"JL Ross","year":"1983","unstructured":"Ross JL, Cassorla FG, Skerda MC et al (1983) A preliminary study of the effect of estrogen dose on growth in Turner\u2019s syndrome. N Engl J Med 309:1104\u20131106","journal-title":"N Engl J Med"},{"key":"247_CR22","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0039-6060(97)90214-2","volume":"122","author":"T Carling","year":"1997","unstructured":"Carling T, Rastad J, Kindmark A, Lundgren E, Ljunghall S, Akerstr\u00f6m G (1997) Estrogen receptor gene polymorphism in postmenopausal primary hyperparathyroidism. Surgery 122:1101\u20131105","journal-title":"Surgery"},{"key":"247_CR23","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2265.2007.03107.x","volume":"68","author":"Z Aycan","year":"2008","unstructured":"Aycan Z, Cetinkaya E, Darendeliler F, Vidinlisan S, Bas F, Bideci A, Demirel F, Darcan S, Buyukgebiz A, Yildiz M, Berberoglu M, Bundak R (2008) The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial. Clin Endocrinol 68:769\u2013772","journal-title":"Clin Endocrinol"},{"key":"247_CR24","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbrc.2004.11.097","volume":"328","author":"F Syed","year":"2005","unstructured":"Syed F, Khosla S (2005) Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun 328:688\u2013696","journal-title":"Biochem Biophys Res Commun"},{"key":"247_CR25","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1210\/jc.2009-0514","volume":"94","author":"N Zuckerman-Levin","year":"2009","unstructured":"Zuckerman-Levin N, Frolova-Bishara T, Militianu D, Levin M, Aharon-Peretz J, Hochberg Z (2009) Androgen replacement therapy in Turner syndrome: a pilot study. J Clin Endocrinol Metab 94:4820\u20134827","journal-title":"J Clin Endocrinol Metab"},{"key":"247_CR26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/er.2003-0003","volume":"25","author":"D Vanderschueren","year":"2004","unstructured":"Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C (2004) Androgenes and bone. Endocr Rev 25:389\u2013425","journal-title":"Endocr Rev"},{"key":"247_CR27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00774-009-0060-z","volume":"27","author":"AW Roddam","year":"2009","unstructured":"Roddam AW, Appleby P, Neale R, Dowsett M, Folkerd E, Tipper S, Allen NE, Key TJ (2009) Association between endogenous plasma hormone concentrations and fracture risk in men and women: the EPIC-Oxford prospective cohort study. J Bone Miner Metab 27:485\u2013493","journal-title":"J Bone Miner Metab"},{"key":"247_CR28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000076531","volume":"61","author":"CT Gallicchio","year":"2004","unstructured":"Gallicchio CT, Figueiredo-Alves ST, Prendin Tortora R, Mendon\u00e7a LM, Farias ML, Guimar\u00e3es MM (2004) Effect of puberty on the relationship between bone markers of turnover and bone mineral density in Turner\u2019s syndrome. Horm Res 61:193\u2013199","journal-title":"Horm Res"},{"key":"247_CR29","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1359\/jbmr.2003.18.5.925","volume":"18","author":"G Khastgir","year":"2003","unstructured":"Khastgir G, Studd JW, Fox SW, Jones J, Alaghband-Zadeh J, Chow JW (2003) A longitudinal study of the effect of subcutaneous estrogen replacement on bone subcutaneous estrogen replacement on bone in young women with Turner\u2019s syndrome. J Bone Miner Res 18:925\u2013932","journal-title":"J Bone Miner Res"},{"key":"247_CR30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1152\/physiolgenomics.00070.2003","volume":"14","author":"M Suuriniemi","year":"2003","unstructured":"Suuriniemi M, Mahonen A, Kovanen V, Al\u00e9n M, Cheng S (2003) Relation of PvuII site polymorphism in the COL1A2 gene to the risk of fractures in prepubertal Finnish girls. Physiol Genomics 14:217\u2013224","journal-title":"Physiol Genomics"},{"key":"247_CR31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-5122(01)00287-0","volume":"41","author":"N Kobayashi","year":"2002","unstructured":"Kobayashi N, Fujino T, Shirogane T, Furuta I, Kobamatsu Y, Yaegashi M, Sakuragi N, Fujimoto S (2002) Estrogen receptor alpha polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen. Maturitas 41:193\u2013201","journal-title":"Maturitas"},{"key":"247_CR32","first-page":"679","volume":"76","author":"A Seremak-Mrozikiewicz","year":"2005","unstructured":"Seremak-Mrozikiewicz A, Drews K, Bartkowiak-Wieczorek J, Kurzawi\u0144ska G, Pie\u0144kowski W, Spaczy\u0144ski M, Mrozikiewicz PM (2005) PvuII genetic polymorphism of estrogen receptor alpha in the group of postmenopausal women with osteopenia and osteoporosis. Ginekol Pol 76:679\u2013686","journal-title":"Ginekol Pol"},{"key":"247_CR33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/09513590802630138","volume":"25","author":"A Brodowska","year":"2009","unstructured":"Brodowska A, Starczewski A, Brodowski J, Szyd\u0142owska I, Nawrocka-Rutkowska J (2009) The bone mass density in postmenopausal women using hormonal replacement therapy in relation to polymorphism in vitamin D receptor and estrogen receptor genes. Gynecol Endocrinol 25:315\u2013323","journal-title":"Gynecol Endocrinol"},{"key":"247_CR34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF03347196","volume":"28","author":"E Bandres","year":"2005","unstructured":"Bandres E, Pombo I, Gonzalez-Huarriz M, Rebollo A, L\u00f3pez G, Garc\u00eda-Foncillas J (2005) Association between bone mineral density and polymorphisms of the VDR, ERalpha, COL1A1 and CTR genes in Spanish postmenopausal women. J Endocrinol Invest 28:312\u2013321","journal-title":"J Endocrinol Invest"},{"key":"247_CR35","first-page":"462","volume":"25","author":"YJ Qin","year":"2004","unstructured":"Qin YJ, Zhang ZL, Huang QR, He JM, Hu YQ, Zhao Q, Lu JH, Li M, Liu YJ (2004) Association of vitamin D receptor and estrogen receptor-alpha gene polymorphism with peak bone mass and bone size in Chinese women. Acta Pharmacol Sin 25:462\u2013468","journal-title":"Acta Pharmacol Sin"},{"key":"247_CR36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1359\/jbmr.2001.16.1.128","volume":"16","author":"OM Albagha","year":"2001","unstructured":"Albagha OM, McGuigan FE, Reid DM, Ralston SH (2001) Estrogen receptor-\u03b1 gene polymorphisms and bone mineral density: haplotype analysis in women from the United Kingdom. J Bone Miner Res 16:128\u2013134","journal-title":"J Bone Miner Res"},{"key":"247_CR37","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s004390050872","volume":"103","author":"HW Deng","year":"1998","unstructured":"Deng HW, Li J, Li JL, Johnson M, Gong G, Davis KM, Recker RR (1998) Change of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen receptor genotypes. Hum Genet 103:576\u2013585","journal-title":"Hum Genet"},{"key":"247_CR38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.gme.0000182804.14385.a2","volume":"13","author":"S Silvestri","year":"2006","unstructured":"Silvestri S, Thomsen AB, Gozzini A, Bagger Y, Christiansen C, Brandi ML (2006) Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy? Menopause 13:451\u2013461","journal-title":"Menopause"},{"key":"247_CR39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7326\/0003-4819-146-5-200703060-00005","volume":"146","author":"SL Greenspan","year":"2007","unstructured":"Greenspan SL, Bone HG, Ettinger MP, Hanley DA, Lindsay R, Zanchetta JR, Blosch CM, Mathisen AL, Morris SA, Marriott TB, Treatment of osteoporosis with Parathyroid Hormone Study Group et al (2007) Effect of recombinant human parathyroid hormone (1\u201384) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med 146:326\u2013339","journal-title":"Ann Intern Med"},{"key":"247_CR40","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1590\/S0004-27302006000400019","volume":"50","author":"M Girotra","year":"2006","unstructured":"Girotra M, Rubin MR, Bilezikian JP (2006) Anabolic skeletal therapy for osteoporosis. Arq Bras Endocrinol Metabol 50:745\u2013754","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"247_CR41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1210\/me.2009-0354","volume":"24","author":"M Martin-Millan","year":"2010","unstructured":"Martin-Millan M, Almeida M, Ambrogini E, Han L, Zhao H, Weinstein RS, Jilka RL, O\u2019Brien CA, Manolagas SC (2010) The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol 24:323\u2013334","journal-title":"Mol Endocrinol"},{"key":"247_CR42","doi-asserted-by":"crossref","unstructured":"Xie H, Sun M, Liao XB, Yuan LQ, Sheng ZF, Meng JC, Wang D, Yu ZY, Zhang LY, Zhou HD, Luo XH, Li H, Wu XP, Wei QY, Tang SY, Wang ZY, Liao EY (2010) Estrogen receptor-alpha36 mediates a bone-sparing effect of 17beta-estrodiol in postmenopausal women. J Bone Miner Res [Epub ahead of print]","DOI":"10.1002\/jbmr.169"},{"key":"247_CR43","first-page":"3","volume":"1","author":"I Orli\u0107","year":"2007","unstructured":"Orli\u0107 I, Borovecki F, Simi\u0107 P, Vukicevi\u0107 S (2007) Gene expression profiling in bone tissue of osteoporotic mice. Arh Hig Rada Toksikol 1:3\u201311","journal-title":"Arh Hig Rada Toksikol"},{"key":"247_CR44","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/EJE-09-0020","volume":"161","author":"L Cleemann","year":"2009","unstructured":"Cleemann L, Hjerrild BE, Lauridsen AL, Heickendorff L, Christiansen JS, Mosekilde L, Gravholt CH (2009) Long-term hormone replacement therapy preserves bone mineral density in Turner syndrome. Eur J Endocrinol 161:251\u2013257","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-010-0247-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-010-0247-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-010-0247-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T23:54:51Z","timestamp":1685922891000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-010-0247-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,27]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["247"],"URL":"https:\/\/doi.org\/10.1007\/s00774-010-0247-3","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,27]]}}}